Sulfonated Ionic Covalent Organic Frameworks With Dual‐State Activation for Synergistic Photodynamic‐Ferroptosis Therapy
Small · 2026-08 · 22 (43)
DOI: 10.1002/smll.74114 ↗Kurz gefasst
Fachartikel in der Zeitschrift Small, online erschienen am 07.06.2026. Verfasst von Jiarong Liang und 6 weiteren Autor:innen. Beteiligte Einrichtung: Spin-X Institute, School of Chemistry and Chemical Engineering, South China University of Technology, Guangzhou, China. Hauptthemen laut MEDLINE: Photochemotherapy, Metal-Organic Frameworks. Die Arbeit nennt 52 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: National Natural Science Foundation of China, Shenzhen Science and Technology Program, National Key Research and Development Program of China.
Abstract (Originalsprache)
Conventional photocatalysis is fundamentally constrained by the competitive nature of excited‐state dynamics, which typically restricts utilization to a single excitonic channel. Consequently, simultaneously harvesting both excitons to maximize reactive oxygen species (ROS) generation remains a formidable challenge in cancer theragnostic. Herein, an ionic engineering strategy is developed to overcome this excitonic bottleneck by constructing sulfonated covalent organic frameworks (BD‐SO 3 ‐COF) via backbone quaternization. This specific ionic modulation imparts a strong push‐pull electronic landscape that fundamentally reshapes excited‐state dynamics. Mechanistically, the sulfonate moieties suppress the parasitic radiative recombination of singlet excitons (S 1 ) to boost superoxide anion (O 2 •− ) generation specifically at the electron‐deficient quaternized pyridine rings (redox sites), while simultaneously populating long‐lived triplet excitons (T 1 ) on the porphyrin macrocycles that activate molecular oxygen via an efficient Dexter energy transfer pathway to produce singlet oxygen ( 1 O 2 ). Capitalizing on this site‐specific dual‐state activation, the engineered COF triggers robust photodynamic therapy (PDT) and induces catastrophic lipid peroxidation, effectively driving cancer cells into ferroptosis. In vivo assessments confirm that this synergistic PDT‐ferroptosis strategy achieves potent tumor regression with minimal systemic toxicity. This work elucidates the critical role of specific active‐site engineering in ionic COFs and provides a paradigm for designing molecular photosensitizers for multi‐modal cancer therapy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Spin-X Institute, School of Chemistry and Chemical Engineering, South China University of Technology, Guangzhou, China.
- School of Materials, Shenzhen Campus of Sun Yat-sen University, Shenzhen, China.
ORCID-Profile: Zhonghui Ma
Förderung
- National Natural Science Foundation of China
- Shenzhen Science and Technology Program
- National Key Research and Development Program of China
- The Medicine-Engineering Convergence Seed Fund (2025) at Sun Yat-sen University.
- Shenzhen Science and Technology Innovation Program
Zitieren
APA
Liang, J., Li, X., Wang, S., Ma, Z., Kuang, F., Duan, M., & Wang, Z. (2026). Sulfonated Ionic Covalent Organic Frameworks With Dual‐State Activation for Synergistic Photodynamic‐Ferroptosis Therapy. Small, 22(43). https://doi.org/10.1002/smll.74114
Vancouver
Liang J, Li X, Wang S, Ma Z, Kuang F, Duan M, et al. Sulfonated Ionic Covalent Organic Frameworks With Dual‐State Activation for Synergistic Photodynamic‐Ferroptosis Therapy. Small. 2026;22(43). doi:10.1002/smll.74114
BibTeX
@article{Liang2026,
author = {Liang, Jiarong and Li, Xiangkun and Wang, Si and Ma, Zhonghui and Kuang, Fei and Duan, Mengdie and Wang, Zhiyi},
title = {Sulfonated Ionic Covalent Organic Frameworks With Dual‐State Activation for Synergistic Photodynamic‐Ferroptosis Therapy},
journal = {Small},
year = {2026},
volume = {22},
number = {43},
doi = {10.1002/smll.74114}
}
EUVIMED